Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1054 | 1013 | 1101 | 963 | 1124 | 1496 |
Fund Return | 5.37% | 1.33% | 10.06% | -1.24% | 2.36% | 4.11% |
Place in category | 2248 | 1064 | 2750 | 2217 | 1415 | 279 |
% in Category | 73 | 36 | 89 | 87 | 65 | 24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dirk Muller Premium Aktien R | 263.31M | 1.35 | -3.70 | - | ||
Warburg Pax Substanz Fonds | 304.02M | 3.24 | 0.20 | 1.74 | ||
Warburg Portfolio Flexibel V | 143.22M | 6.84 | -0.41 | 2.14 | ||
Warburg Portfolio Flexibel A | 143.22M | 6.84 | -0.41 | 2.26 | ||
Warburg Portfolio Flexibel T | 143.22M | 7.02 | -0.71 | 2.34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PrivatFonds: Kontrolliert pro | 2.5B | 11.07 | 2.21 | 3.85 | ||
BBBank Kontinuitat Union | 1.38B | 5.94 | 2.44 | 3.52 | ||
Substanz Fonds | 1.29B | 6.80 | 0.49 | 4.63 | ||
UniStrategie:Ausgewogen | 1.14B | 2.93 | 1.68 | 3.89 | ||
Allianz Strategiefonds Balance PT2 | 101.03M | 11.11 | 4.90 | 5.80 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SQUAD – European Convictions I | LU1659686460 | 4.64 | - | - | |
Lyxor Core MSCI Japan (DR) | LU1781541252 | 1.65 | 17.44 | -0.80% | |
Roche Holding Participation | CH0012032048 | 1.03 | 255.80 | -2.22% | |
Novartis | CH0012005267 | 1.00 | 91.71 | -1.10% | |
Nestle | CH0038863350 | 0.99 | 77.52 | -1.55% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review